
Gary W. Counts
Examiner (ID: 6122, Phone: (571)272-0817 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1641, 1677 |
| Total Applications | 1270 |
| Issued Applications | 600 |
| Pending Applications | 185 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15471021
[patent_doc_number] => 10551379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Methods and compositions for improving detection and/or capture of a target entity
[patent_app_type] => utility
[patent_app_number] => 14/766575
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 41195
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/766575 | Methods and compositions for improving detection and/or capture of a target entity | Mar 13, 2014 | Issued |
Array
(
[id] => 16428445
[patent_doc_number] => 10828507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Clinical decision support (CDS) for radiotherapy in prostate cancer
[patent_app_type] => utility
[patent_app_number] => 14/770482
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 7050
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770482
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770482 | Clinical decision support (CDS) for radiotherapy in prostate cancer | Mar 6, 2014 | Issued |
Array
(
[id] => 9970951
[patent_doc_number] => 09017958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Method of simultaneous detection of heparin-induced immunoglobulins types G, A, and M'
[patent_app_type] => utility
[patent_app_number] => 14/193391
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 8140
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193391 | Method of simultaneous detection of heparin-induced immunoglobulins types G, A, and M | Feb 27, 2014 | Issued |
Array
(
[id] => 10484807
[patent_doc_number] => 20150369826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'METHOD FOR PREVENTING DETERIORATION OF UNSENSITIZED LATEX REAGENT'
[patent_app_type] => utility
[patent_app_number] => 14/766329
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6055
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/766329 | METHOD FOR PREVENTING DETERIORATION OF UNSENSITIZED LATEX REAGENT | Feb 17, 2014 | Abandoned |
Array
(
[id] => 9672303
[patent_doc_number] => 20140236166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'BIOMARKERS FOR DISTINGUISHING BENIGN, PRE-MALIGNANT, AND MALIGNANT PANCREATIC CYSTS'
[patent_app_type] => utility
[patent_app_number] => 14/180892
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19509
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14180892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/180892 | BIOMARKERS FOR DISTINGUISHING BENIGN, PRE-MALIGNANT, AND MALIGNANT PANCREATIC CYSTS | Feb 13, 2014 | Abandoned |
Array
(
[id] => 9537732
[patent_doc_number] => 20140162378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'METHOD FOR DETECTING TARGET PARTICLE'
[patent_app_type] => utility
[patent_app_number] => 14/179174
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19964
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179174 | Method for detecting target particle | Feb 11, 2014 | Issued |
Array
(
[id] => 10116052
[patent_doc_number] => 09150924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Bin1 as a prognostic marker in cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 14/176985
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 16
[patent_no_of_words] => 17885
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14176985
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/176985 | Bin1 as a prognostic marker in cardiovascular disease | Feb 9, 2014 | Issued |
Array
(
[id] => 10431528
[patent_doc_number] => 20150316541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'METHOD FOR IMMUNOLOGICALLY ASSAYING HEMOGLOBIN A1C IN SPECIMEN'
[patent_app_type] => utility
[patent_app_number] => 14/655277
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4856
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655277
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655277 | METHOD FOR IMMUNOLOGICALLY ASSAYING HEMOGLOBIN A1C IN SPECIMEN | Dec 25, 2013 | Abandoned |
Array
(
[id] => 9569807
[patent_doc_number] => 20140187519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'BIOMARKERS FOR PREDICTING MAJOR ADVERSE EVENTS'
[patent_app_type] => utility
[patent_app_number] => 14/095053
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 72211
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095053
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/095053 | BIOMARKERS FOR PREDICTING MAJOR ADVERSE EVENTS | Dec 2, 2013 | Abandoned |
Array
(
[id] => 9670991
[patent_doc_number] => 20140234854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'METHOD FOR EVALUATION OF PRESENCE OF OR RISK OF COLON TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/094594
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 28121
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14094594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/094594 | METHOD FOR EVALUATION OF PRESENCE OF OR RISK OF COLON TUMORS | Dec 1, 2013 | Abandoned |
Array
(
[id] => 13108909
[patent_doc_number] => 10073097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
[patent_app_type] => utility
[patent_app_number] => 14/092443
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 14474
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/092443 | Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome | Nov 26, 2013 | Issued |
Array
(
[id] => 10424006
[patent_doc_number] => 20150309017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'NON-COMPETITIVE IMMUNOASSAYS TO DETECT SMALL MOLECULES USING NANOPEPTAMERS'
[patent_app_type] => utility
[patent_app_number] => 14/648242
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15945
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648242 | Non-competitive immunoassays to detect small molecules using nanopeptamers | Nov 25, 2013 | Issued |
Array
(
[id] => 9720211
[patent_doc_number] => 20140255912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Sample Collection and Analysis'
[patent_app_type] => utility
[patent_app_number] => 14/089103
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4486
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/089103 | Sample collection and analysis | Nov 24, 2013 | Issued |
Array
(
[id] => 10027097
[patent_doc_number] => 09068994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues'
[patent_app_type] => utility
[patent_app_number] => 14/087286
[patent_app_country] => US
[patent_app_date] => 2013-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 15653
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14087286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/087286 | TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues | Nov 21, 2013 | Issued |
Array
(
[id] => 11643317
[patent_doc_number] => 09664682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Assay to measure midkine or pleiotrophin level for diagnosing a growth'
[patent_app_type] => utility
[patent_app_number] => 14/646078
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8952
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646078
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646078 | Assay to measure midkine or pleiotrophin level for diagnosing a growth | Nov 14, 2013 | Issued |
Array
(
[id] => 9561144
[patent_doc_number] => 20140178857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Method'
[patent_app_type] => utility
[patent_app_number] => 14/079514
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9022
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14079514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/079514 | Method | Nov 12, 2013 | Abandoned |
Array
(
[id] => 11069183
[patent_doc_number] => 20160266147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 15/035004
[patent_app_country] => US
[patent_app_date] => 2013-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23101
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035004 | Method for diagnosing inflammatory bowel disease | Nov 6, 2013 | Issued |
Array
(
[id] => 9756739
[patent_doc_number] => 20140287440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'Melittin Peptide Conjugates and Methods Employing Same'
[patent_app_type] => utility
[patent_app_number] => 14/064237
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9215
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14064237
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/064237 | Melittin Peptide Conjugates and Methods Employing Same | Oct 27, 2013 | Abandoned |
Array
(
[id] => 10416045
[patent_doc_number] => 20150301056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'METHYLGLYOXAL AS A MARKER OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/437911
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15856
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437911
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437911 | METHYLGLYOXAL AS A MARKER OF CANCER | Oct 24, 2013 | Abandoned |
Array
(
[id] => 10400782
[patent_doc_number] => 20150285791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'METHOD FOR INCREASING THE SENSITIVITY OF IMMUNOASSAY SYSTEM THROUGH PRETREATMENT OF URINE WITH DENATURANT'
[patent_app_type] => utility
[patent_app_number] => 14/437568
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5554
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437568 | Method for increasing the sensitivity of immunoassay system through pretreatment of urine with denaturant | Oct 22, 2013 | Issued |